Method for treating cancer with Toxoplasma gondii vaccine
US9757440B2 · kind B2 · utility
0Cited by
3References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 2011 |
| Grant date | Sep 12, 2017 |
| Priority date | — |
| Expiry date | Mar 4, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/585
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides attenuated Toxoplasma gondii mutants for use as vaccines in the prevention or treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.